相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models
Janice M. Santiago-O'Farrill et al.
CANCER (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
The Core-Clock Gene NR1D1 Impacts Cell Motility In Vitro and Invasiveness in a Zebrafish Xenograft Colon Cancer Model
Alireza Basti et al.
CANCERS (2020)
SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway
Mo Chen et al.
AGING-US (2020)
TFEB is a master regulator of tumor-associated macrophages in breast cancer
Yong Li et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
The circadian rhythm and core gene Period2 regulate the chemotherapy effect and multidrug resistance of ovarian cancer through the PI3K signaling pathway
Zhaoxia Wang et al.
BIOSCIENCE REPORTS (2020)
Circadian disruption promotes tumor-immune microenvironment remodeling favoring tumor cell proliferation
I Aiello et al.
SCIENCE ADVANCES (2020)
Treatment of epithelial ovarian cancer
Lindsay Kuroki et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Circadian Clock Protein PERIOD2 Suppresses the PI3K/Akt Pathway and Promotes Cisplatin Sensitivity in Ovarian Cancer
Zhaoxia Wang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease
Gillian A. Durham et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian Cancer
Wei Wen et al.
TRANSLATIONAL ONCOLOGY (2019)
High expression of NR1D1 is associated with good prognosis in triple-negative breast cancer patients treated with chemotherapy
Hyelin Na et al.
BREAST CANCER RESEARCH (2019)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence
Gabriele Sulli et al.
NATURE (2018)
Understanding SOCS protein specificity
Edmond M. Linossi et al.
GROWTH FACTORS (2018)
Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma
Qingming Tang et al.
CANCER RESEARCH (2017)
Circadian Clock, Cell Division, and Cancer: From Molecules to Organism
Anton Shostak
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
NR1D1 enhances oxidative DNA damage by inhibiting PARP1 activity
Na-Lee Ka et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
Bernd Groner et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer
An-Quan Shang et al.
CANCER BIOLOGY & THERAPY (2017)
NR1D1 Recruitment to Sites of DNA Damage Inhibits Repair and Is Associated with Chemosensitivity of Breast Cancer
Na-Lee Ka et al.
CANCER RESEARCH (2017)
Constitutive activation of STAT3 in breast cancer cells: A review
Kasturi Banerjee et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
被撤回的出版物: Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis (Retracted article. See vol. 42, 2023)
Li Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
NR1D1 ameliorates Mycobacterium tuberculosis clearance through regulation of autophagy
Vemika Chandra et al.
AUTOPHAGY (2015)
Anti-proliferative actions of a synthetic REV-ERBα/β agonist in breast cancer cells
Yongjun Wang et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth
Galina Gritsina et al.
MOLECULAR CANCER THERAPEUTICS (2015)
SOCS3 blocks HIF-1 expression to inhibit proliferation and angiogenesis of human small cell lung cancer by downregulating activation of Akt, but not STAT3
Jun Wan et al.
MOLECULAR MEDICINE REPORTS (2015)
Retinoic acid amide inhibits JAK/STAT pathway in lung cancer which leads to apoptosis
Hong-Xing Li et al.
TUMOR BIOLOGY (2015)
Circadian Disruption and Fatal Ovarian Cancer
Brian D. Carter et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2014)
Loss of Suppressors of Cytokine Signaling 3 Promotes Aggressiveness in Hepatocellular Carcinoma
Wen-Yong Wu et al.
JOURNAL OF INVESTIGATIVE SURGERY (2014)
Targeting JAK1/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer
Wei Wen et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor
Andrew J. Brooks et al.
SCIENCE (2014)
Nuclear receptor Rev-erbα: up, down, and all around
Logan J. Everett et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
The biology and mechanism of action of suppressor of cytokine signaling 3
Jeffrey J. Babon et al.
GROWTH FACTORS (2012)
Suppressors of Cytokine Signaling (SOCS) Proteins and JAK/STAT Pathways Regulation of T-Cell Inflammation by SOCS1 and SOCS3
Taiga Tamiya et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Rev-erb-α: an integrator of circadian rhythms and metabolism
Helene Duez et al.
JOURNAL OF APPLIED PHYSIOLOGY (2009)
Carcinogenicity of shift-work, painting, and fire-fighting
Kurt Straif et al.
LANCET ONCOLOGY (2007)
The role of constitutively active signal transducer and activator of transcription 3 in ovarian turnorigenesis and prognosis
Daniel G. Rosen et al.
CANCER (2006)
分享论文
